1. Scrip
  2. >>Business
  3. >>Financing

Autolus On The Rise After Big Backing From Blackstone

Private Equity Group Investing Up To $250m

 
• By Kevin Grogan

The cash injection comes as a potentially pivotal trial of Autolus's next-generation leukemia CAR-T therapy continues to enrol ahead of a readout in 2022.

money river
Money river flowing for Autolus • Source: Shutterstock

Autolus Therapeutics plc stock is soaring after the firm secured one of the largest-ever private financings of a UK biotech, and the largest from a single source, to fund the final stages of development of its next-generation blood cancer CAR-T therapy obecabtagene autoleucel (obe-cel).

Private equity giant Blackstone is investing as much as $250m in the London-headquartered biotech, made up of $100m for a stake in Autolus and another $150m to support development and commercialization of obe-cell

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Financing

More from Business

Roche Reveals Another US Manufacturing Site As Tariff Pressures Seem To Ease

 
• By Mandy Jackson

Roche/Genentech unveiled plans for a $700m-plus manufacturing facility for weight loss drugs in North Carolina as President Trump signaled such investments could mean no tariffs for pharma.

Trump’s MFN Executive Order More Rhetoric Than Action

 
• By Jessica Merrill

The details of Trump’s latest executive order on drug pricing are vague and the president put more blame on other countries and pharma distributors than drug companies.

Biopharma Deals ROI Has Fallen And Market Instability Could Make It Worse

 
• By Andrew McConaghie

Rising biotech valuations mean return on investment on some deals is non-existent for big pharma, though certain strategies will improve chances of success, a new analysis has found.